Analysis of cytokine production by inflammatory mouse macrophages at the single‐cell level: selective impairment of IL‐12 induction in Leishmania ‐infected cells

Intracellular staining for cytokines and parasites, combined with two‐color flow cytometric analyses, were used to examine the frequencies of IL‐12‐, TNF‐α‐ and IL‐6‐producing macrophages in response to Leishmania major infection and/or activation with IFN‐γ/lipopolysaccharide (LPS). Inflammatory macrophages were obtained from nonimmune granulomas, initiated by the injection of polyacrylamide microbeads (Bio‐gel P‐100) into subcutaneous pouches of different mouse strains. Infection of inflammatory macrophages in vitro using metacyclic promastigotes produced identical effects on cytokine responses regardless of whether cells from genetically resistant or susceptible mouse strains were used: IL‐12 was not produced in response to infection itself, virtually every infected cell lost its ability to produce IL‐12 in response to IFN‐γ/LPS, and the IL‐6 response was partially inhibited, while the TNF‐α response of infected cells was unimpaired. Low‐multiplicity infection of inflammatory macrophages in vivo using either metacyclic promastigotes or tissue amastigotes also resulted in the complete and selective inhibition of IL‐12 responses in infected cells. These data establish the physiologic relevance of prior observations regarding the selective impairment of IL‐12 induction pathways in infected macrophages, and suggest a mechanisms for the delayed onset of cell‐mediated control mechanisms that is typical of even self‐limiting forms of leishmanial disease.

[1]  B. Kelsall,et al.  Regulation of Interleukin-12 by Complement Receptor 3 Signaling , 1997, The Journal of experimental medicine.

[2]  V. Maino,et al.  Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations , 1995, The Journal of experimental medicine.

[3]  G. Trinchieri Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.

[4]  R. Schaub,et al.  Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response , 1993, The Journal of experimental medicine.

[5]  R. Rerko,et al.  Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. , 1995, Journal of immunology.

[6]  W. Beil,et al.  Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice , 1992, Journal of leukocyte biology.

[7]  D. Riches Signalling heterogeneity as a contributing factor in macrophage functional diversity. , 1995, Seminars in cell biology.

[8]  G. Trinchieri,et al.  Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells. , 1997, Journal of immunology.

[9]  G. Trinchieri,et al.  Mechanism of Suppression of Cell-Mediated Immunity by Measles Virus , 1996, Science.

[10]  I. Katzenellenbogen VACCINATION AGAINST ORIENTAL SORE: REPORT OF RESULTS OF FIVE HUNDRED AND FIFTY-FIVE INOCULATIONS , 1944 .

[11]  P. Kaye,et al.  Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro , 1992, Infection and immunity.

[12]  G. Trinchieri,et al.  IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. , 1995, Journal of immunology.

[13]  R. Rerko,et al.  Recombinant interleukin 12 cures mice infected with Leishmania major , 1993, The Journal of experimental medicine.

[14]  A. Sher,et al.  Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. , 1996, The Journal of infectious diseases.

[15]  P. Kaye,et al.  Dendritic cells, but not macrophages, produce IL‐12 immediately following Leishmania donovani infection , 1998, European journal of immunology.

[16]  D. Berberian CUTANEOUS LEISHMANIASIS (ORIENTAL SORE): I. TIME REQUIRED FOR DEVELOPMENT OF IMMUNITY AFTER VACCINATION , 1944 .

[17]  S. Frankenburg,et al.  In vitro secretion of cytokines by human mononuclear cells of individuals during and after cutaneous leishmaniasis infection , 1993, Parasite immunology.

[18]  G. Trinchieri,et al.  Infection with Leishmania major induces interleukin-12 production in vivo. , 1994, Immunology letters.

[19]  A Radbruch,et al.  Flow cytometric determination of cytokines in activated murine T helper lymphocytes: Expression of interleukin‐10 in interferon‐γ and in interleukin‐4‐expressing cells , 1994, European journal of immunology.

[20]  P. Kaye,et al.  An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice. , 1996, Experimental parasitology.

[21]  R. Locksley,et al.  Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection , 1994, The Journal of experimental medicine.

[22]  D. Snary,et al.  Monoclonal antibodies to Leishmania tropica major: specificities and antigen location , 1982, Parasitology.

[23]  H. Murray Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis. , 1997, The Journal of infectious diseases.

[24]  W. de Souza,et al.  Isolation and purification of amastigotes of Leishmania mexicana amazonensis by a gradient of Metrizamide. , 1983, The Journal of parasitology.

[25]  Y. Belkaid,et al.  Transient inducible events in different tissues: in situ studies in the context of the development and expression of the immune responses to intracellular pathogens. , 1994, Immunobiology.

[26]  A. Sher,et al.  Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. , 1985, Journal of immunology.

[27]  A. Descoteaux,et al.  The lipophosphoglycan of Leishmania and macrophage protein kinase C. , 1993, Parasitology today.

[28]  N. Reiner,et al.  Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. , 1987, Journal of immunology.

[29]  J. Louis,et al.  Genetically resistant mice lacking interleukin‐12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response , 1996, European journal of immunology.

[30]  P. Melby Experimental leishmaniasis in humans: review. , 1991, Reviews of infectious diseases.

[31]  F. Sutterwala,et al.  Selective Suppression of Interleukin-12 Induction after Macrophage Receptor Ligation , 1997, The Journal of experimental medicine.

[32]  R. Epand,et al.  Transbilayer inhibition of protein kinase C by the lipophosphoglycan from Leishmania donovani. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  E. Unanue,et al.  Natural Immunity: A T‐Cell‐Independent Pathway of Macrophage Activation, Defined in the scid Mouse , 1991, Immunological reviews.

[34]  D. Metcalfe,et al.  Flow cytometric analysis for cytokine production identifies T helper 1, T helper 2, and T helper 0 cells within the human CD4+CD27- lymphocyte subpopulation. , 1995, Journal of immunology.

[35]  R. Fauve,et al.  Maintenance of granuloma macrophages in serum-free medium. , 1983, Journal of immunological methods.

[36]  R. Badolato,et al.  Promastigotes Selectively Inhibit Interleukin 12 Induction in Bone Marrow-derived Macrophages from Susceptible and Resistant Mice , 1996 .

[37]  E. Carvalho,et al.  Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis. , 1995, The American journal of tropical medicine and hygiene.

[38]  G. Trinchieri,et al.  Impaired interleukin 12 production in human immunodeficiency virus- infected patients , 1994, The Journal of experimental medicine.

[39]  T. Hamilton,et al.  The activated macrophage and granulomatous inflammation. , 1989, Current topics in pathology. Ergebnisse der Pathologie.